Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05487313 |
Other study ID # |
2022-01-026-02 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
August 12, 2022 |
Est. completion date |
March 21, 2023 |
Study information
Verified date |
March 2023 |
Source |
Keimyung University Dongsan Medical Center |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The primary endpoint of this study was to identify if the ESPB in the patients of cervical
radiculopathy has the effect of pain relief. The secondary endpoint of this study was to
identify the spread level in the craniocaudal direction when performed at the T2 level.
Description:
The ESPB requires ultrasound guidance which enables visible local anesthetic spread
underneath the erector spinae muscles. The spinalis, longissimus thoracis, and iliocostalis
muscles comprise the ES muscles, which run vertically along both sides of the vertebral
column from the sacrum up to the skull base (1,10). The ESPB can be performed in the
cervical, thoracic, and lumbar regions. Among them, upper or mid thoracic ESPB has been used
more widely compared to cervical and lumbar regions.
Previous cadaveric studies on the ESPB at the T5 level using computed tomography (CT)
reconstruction or direct dissection demonstrated the extensive craniocaudal distribution of
methylene blue ranging from T1 to T8 vertebral segments deep to the ES muscles and variable
involvement of epidural, paravertebral, and intercostal spaces. The ESPB performed at the T2
level of the cadaver demonstrated an injected dye distribution ranging from C4 to T10. Also,
36% of cadavers showed the spread of an injected dye to the ventral, dorsal ramus,
paravertebral space, and even the contralateral side.
The exact mechanism of action of ESPB remains unclear. A recent study suggested that the
analgesic effect of ESPB could be obtained by blocking the ventral and dorsal ramus of the
spinal nerves by passing through the costotransverse foramen. However, in clinical practice,
we can encounter highly variable clinical outcomes or sensory block after the ESPB. The study
of the physical spread of the injected agent can be used to predict the clinical result and
elucidate the possible mechanism of action of ESPB.